Factors predicting lower extremity amputations in patients with type 1 or type 2 diabetes mellitus: A population-based 7-year follow-up study

Journal of Internal Medicine

Volumn 246, Issue 1, 1999, Pages 97-103

  Hämäläinen, Helena ^a   Ronnemaa T ^b   Halonen, J P ^b   Toikka, T ^a  

^a SOCIAL INSURANCE INSTITUTION   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Amputation; Complications; Diabetes mellitus; Neuropathy

Indexed keywords

ADULT; AGED; ARTICLE; CLAUDICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; HUMAN; KIDNEY DISEASE; LEG AMPUTATION; LEG BLOOD FLOW; MALE; NEUROPATHY; PRIORITY JOURNAL; RETINOPATHY; RISK FACTOR;

EID: 0032786510     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1999.00523.x     Document Type: Article

References (30)

1. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983; 6: 87-91.
2. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyörälä K. Lower-extremity amputations in diabetic and nondiabetic patients. Diabetes Care 1983; 16: 16-20.
3. Humphrey LL, Palumbo PJ, Butters MA, et al. The contribution of non-insulin-dependent diabetes to lower-extremity amputation in the community. Arch Intern Med 1994; 154: 885-92.
4. Moss SE, Klein R, Klein BEK. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 1992; 152: 610-6.
5. Nelson RG, Gohdes DM, Everhart JE, et al. Lower-extremity amputations in NIDDM. 12-yr follow-up study in Pima Indians. Diabetes Care 1988; 11: 8-16.
6. Kreines K, Johnson E, Albrink M, et al. The course of peripheral vascular disease in non-insulin-dependent diabetes. Diabetes Care 1985; 8: 235-43.
7. Lee JS, Lu M, Lee VS, Russell D, Bahr C, Lee ET. Lower extremity amputation. Incidence, risk factors, and mortality is the Oklaholma Indian Diabetes Study. Diabetes 1993; 42: 876-82.
8. Selby JV, Zhang D. Risk factors for lower extremity amputation in persons with diabetes. Diabetes Care 1995; 18: 509-16.
9. Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 1996; 19: 607-12.
10. Mayfield JA, Reiber GE, Nelson RG, Greene T. A fool risk classification system to predict diabetic amputation in Pima Indians. Diabetes Care 1996; 19: 704-9.
11. Humphrey ARG, Dowse GK, Thoma K, Zimmet PZ. Diabetes and nontraumatic lower extremity amputations. Diabetes Care 1996; 19: 710-4.
12. Rönnemaa T, Liukkonen I, Knuts L-R, Seppälä P, Kallio V. Prevalence of foot problems and need for foot care in an unselected diabetic population. J Br Podiatr Med 1993; 48: 185-90.
13. Rönnemaa, T, Hämäläinen H, Toikka T, Liukkonen I. Evaluation of the impact of podiatrist care in the primary prevention of foot problems in diabetic subjects. Diabetes Care 1997; 20: 1833-7.
14. Rose GA, Blackburn H. Monograph series 56. Cardiovascular Survey Methods Geneva: WHO, 1968.
15. Johnson RN, Metcalf PA, Baker JR. Fructosamine: a new approach to the estimation of serum glycosylprotein, an index of diabetic control. Clin Chim Acta 1983; 127: 87-95.
16. Siedel J, Hagele E, Zeigenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983; 29: 1075-80.
17. Kostner GM. Enzymatic determination of cholesterol in high lipoprotein fractions by polyanion precipitation. Clin Chem 1976; 22: 695.
18. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice, 2nd edn. Philadelphia: F.A. Davis Company, 1989; 78-102.
19. Goldberg JM, Lindblom U. Standardized method for determining vibratory perception thresholds for diagnosis and screening in neurological investigation. J Neurol Neurosurg Psychiatr 1979; 42: 795-803.
20. Halonen J-P, Mäki J. Population-based reference values in nerve conduction studies (Abstract). Electroencephalogr Clin Neurophysiology 1993; 87: 103.
21. Halonen P. Quantitative vibration perception thresholds in healthy subjects of working age. Eur J Appl Physiol 1986; 54: 647-55.
22. SAS Institute Inc. SAS/STAT User's Guide. Version 6, Vols 1 and 2. 4th edn. Cary. NC: SAS Institute Inc., 1990.
23. Coppini DV, Young PJ, Weng C, MacLeod AF, Sönksen PH. Outcome of diabetic fool complications in relation to clinical examination and quantitative sensory testing: a case-control study. Diabetic Med 1998; 15: 765-71.
24. Tooke JE, Brash PD. Microvascular aspects of diabetic foot disease. Diabetic Med 1996; 13; S26-9.
25. Larsson J, Apelquist J. Towards less amputations in diabetic patients. Incidence, causes, cost, treatment, and prevention - review. Acta Orthop Scand 1995; 66: 181-92.
26. Takolander R, Rauwerda JA. The use of non-invasive vascular assessment in diabetic patients with foot lesions. Diabetic Med 1996; 13: S39-42.
27. Armbruster DA. Fructosamine: structure, analysis, and clinical usefulness. Clin Chem 1987; 33: 2153-63.
28. Ardawi MSM, Nasrat HAN, Bahnassy AA. Fructosamine in obese normal subjects and type 2 diabetes. Diabetic Med 1994; 11: 50-6.
29. DCCT Research Group. The effects of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Eng J Med 1993; 329: 977-86.
30. Reddy DM, Fleming R, Adesso VJ. Gender and health. In: Maes S, Leventh H, Johnston M, eds. International Review of Health Psychology. Vol. 1 Chichester: Wiley, 1992; 3-32.